Ischemic cardiomyopathy(ICM)affect millions of patients globally.Decellularized extracellular matrix materials(dECM)have components,microstructure and mechanical properties similar to healthy cardiac tissues,and can b...Ischemic cardiomyopathy(ICM)affect millions of patients globally.Decellularized extracellular matrix materials(dECM)have components,microstructure and mechanical properties similar to healthy cardiac tissues,and can be manufactured into various forms of implantable biomaterials including injectable hydrogels or epicardial patches,which have been extensively reported to attenuate pathological left ventricular remodeling and maintain heart function.Recently,dECM medical devices for ICM treatment have been approved for clinical use or studied in clinical trials,exhibiting considerable translation potential.Cells,growth factors and other bioactive agents have been incorporated with different dECM materials to improve the therapeutic outcomes.In addition,more detailed aspects of the biological effects and mechanisms of dECM treatment are being revealed.This review summarized recent advances in dECM materials from variable sources for cardiac repair,including extraction of extracellular matrix,cell integration,smart manufacturing of injectable hydrogels and cardiac patch materials,and their therapeutic applications.Besides,this review provides an outlook on the cutting-edge development directions in the field.展开更多
基金supported by the National Key Research and Development Program of China(no.2019YFE0117400)National Natural Science Foundation of China(no.82202328)Fundamental Research Funds for the Central Universities(226-2023-00066).
文摘Ischemic cardiomyopathy(ICM)affect millions of patients globally.Decellularized extracellular matrix materials(dECM)have components,microstructure and mechanical properties similar to healthy cardiac tissues,and can be manufactured into various forms of implantable biomaterials including injectable hydrogels or epicardial patches,which have been extensively reported to attenuate pathological left ventricular remodeling and maintain heart function.Recently,dECM medical devices for ICM treatment have been approved for clinical use or studied in clinical trials,exhibiting considerable translation potential.Cells,growth factors and other bioactive agents have been incorporated with different dECM materials to improve the therapeutic outcomes.In addition,more detailed aspects of the biological effects and mechanisms of dECM treatment are being revealed.This review summarized recent advances in dECM materials from variable sources for cardiac repair,including extraction of extracellular matrix,cell integration,smart manufacturing of injectable hydrogels and cardiac patch materials,and their therapeutic applications.Besides,this review provides an outlook on the cutting-edge development directions in the field.
